ClinicalTrialsFinder

CEMDOE - Centro Médico de Diabetes, Obesidad y Especialidades ( Site 2901)

Santo Domingo, Nacional, Dominican Republic

1 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Crohn's Disease
Merck Sharp & Dohme LLC1,200 enrolled499 locationsNCT06430801